The Warburg effect: 80 years on

Biochemical Society Transactions

Volumn 44, Issue 5, 2016, Pages 1499-1505

  Potter, Michelle ^a   Newport, Emma ^a   Morten, Karl J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; LACTIC ACID; ADENOSINE TRIPHOSPHATE;

ARTICLE; BIOENERGY; CANCER CELL; EXCRETION; GLYCOLYSIS; HUMAN; METABOLIC REGULATION; MITOCHONDRIAL RESPIRATION; OXIDATIVE PHOSPHORYLATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; BIOLOGICAL MODEL; ENERGY METABOLISM; METABOLISM; MITOCHONDRION; NEOPLASM; PATHOLOGY;

ADENOSINE TRIPHOSPHATE; ENERGY METABOLISM; GLUCOSE; GLYCOLYSIS; HUMANS; LACTIC ACID; MITOCHONDRIA; MODELS, BIOLOGICAL; NEOPLASMS; OXIDATIVE PHOSPHORYLATION;

EID: 85009874531     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20160094     Document Type: Article

References (57)

1. Warburg, O., Wind, F. and Negelein, E. (1927) The metabolism of tumors in the body. J. Gen. Physiol. 8, 519-530 doi:10.1085/jgp.8.6.519
2. Cori, C.A. and Cori, G.T. (1925) The carbohydrate metabolism of tumours. J. Biol. Chem. 65, 397-405
3. Sakashita, M., Aoyama, N., Minami, R., Maekawa, S., Kuroda, K., Shirasaka, D. et al. (2001) Glut1 expression in T1 and T2 stage colorectal carcinomas: its relationship to clinicopathological features. Eur. J. Cancer 37, 204-209 doi:10.1016/S0959-8049(00)00371-3
4. Grover-McKay, M., Walsh, S.A., Seftor, E.A., Thomas, P.A. and Hendrix, M.J.C. (1998) Role for glucose transporter 1 protein in human breast cancer. Pathol. Oncol. Res. 4, 115-120 doi:10.1007/BF02904704
5. Wu, M., Neilson, A., Swift, A.L., Moran, R., Tamagnine, J., Parslow, D. et al. (2007) Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am. J. Physiol. Cell Physiol. 292, C125-C136 doi:10.1152/ajpcell.00247.2006
6. Lai, J.-H., Jan, H.-J., Liu, L.-W., Lee, C.-C., Wang, S.-G., Hueng, D.-Y. et al. (2013) Nodal regulates energy metabolism in glioma cells by inducing expression of hypoxia-inducible factor 1a. Neuro-Oncology 15, 1330-1341 doi:10.1093/neuonc/not086
7. Michelakis, E.D., Sutendra, G., Dromparis, P., Webster, L., Haromy, A., Niven, E. et al. (2010) Metabolic modulation of glioblastoma with dichloroacetate. Sci. Transl. Med. 2, 31ra34 doi:10.1126/scitranslmed.3000677
8. Warburg, O. (1956) On the origin of cancer cells. Science 123, 309-314 doi:10.1126/science.123.3191.309
9. Warburg, O. (1956) On respiratory impairment in cancer cells. Science 124, 269-270 PMID: 13351639
10. DeBerardinis, R.J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S. et al. (2007) Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl Acad. Sci. USA 104, 19345-19350 doi:10.1073/pnas.0709747104
11. Fantin, V.R., St-Pierre, J. and Leder, P. (2006) Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9, 425-434 doi:10.1016/j.ccr.2006.04.023
12. Schulz, T.J., Thierbach, R., Voigt, A., Drewes, G., Mietzner, B., Steinberg, P. et al. (2006) Induction of oxidative metabolism by mitochondrial frataxin inhibits cancer growth: OTTO WARBURG REVISITED. J. Biol. Chem. 281, 977-981 doi:10.1074/jbc.M511064200
13. Ju, Y.S., Alexandrov, L.B., Gerstung, M., Martincorena, I., Nik-Zainal, S., Ramakrishna, M. et al. (2014) Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer. eLife 3, e02935 doi:10.7554/eLife.02935
14. Xu, X.D., Shao, S.X., Jiang, H.P., Cao, Y.W., Wang, Y.H., Yang, X.C. et al. (2015) Warburg effect or reverse Warburg effect? A review of cancer metabolism. Oncol. Res. Treat. 38, 117-122 doi:10.1159/000375435
15. Weinhouse, S. (1967) Hepatomas. Science 158, 542-545 doi:10.1126/science.158.3800.542
16. Jose, C., Bellance, N. and Rossignol, R. (2011) Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma? Biochim. Biophys. Acta, Bioenerg. 1807, 552-561 doi:10.1016/j.bbabio.2010.10.012
17. Moreno-Sánchez, R., Rodríguez-Enríquez, S., Marín-Hernández, A. and Saavedra, E. (2007) Energy metabolism in tumor cells. FEBS J. 274, 1393-1418 doi:10.1111/j.1742-4658.2007.05686.x
18. Martin, M., Beauvoit, B., Voisin, P.J., Canioni, P., Guérin, B. and Rigoulet, M. (1998) Energetic and morphological plasticity of C6 glioma cells grown on 3-D support; effect of transient glutamine deprivation. J. Bioenerg. Biomembr. 30, 565-578 doi:10.1023/A:1020584517588
19. Obre, E. and Rossignol, R. (2015) Emerging concepts in bioenergetics and cancer research: metabolic flexibility, coupling, symbiosis, switch, oxidative tumors, metabolic remodeling, signaling and bioenergetic therapy. Int. J. Biochem. Cell Biol. 59, 167-181 doi:10.1016/j.biocel.2014.12.008
20. Zu, X.L. and Guppy, M. (2004) Cancer metabolism: facts, fantasy, and fiction. Biochem. Biophys. Res. Commun. 313, 459-465 doi:10.1016/j.bbrc. 2003.11.136
21. Astuti, D., Latif, F., Dallol, A., Dahia, P.L.M., Douglas, F., George, E. et al. (2001) Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am. J. Hum. Genet. 69, 49-54 doi:10.1086/321282
22. Baysal, B.E., Ferrell, R.E., Willett-Brozick, J.E., Lawrence, E.C., Myssiorek, D., Bosch, A. et al. (2000) Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287, 848-851 doi:10.1126/science.287.5454.848
23. Dang, L., White, D.W., Gross, S., Bennett, B.D., Bittinger, M.A., Driggers, E.M. et al. (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739-744 doi:10.1038/nature08617
24. Yan, H., Bigner, D.D., Velculescu, V. and Parsons, D.W. (2009) Mutant metabolic enzymes are at the origin of gliomas. Cancer Res. 69, 9157-9159 doi:10.1158/0008-5472.CAN-09-2650
25. Hanahan, D. and Weinberg, R.A. (2000) The hallmarks of cancer. Cell 100, 57-70 doi:10.1016/S0092-8674(00)81683-9
26. Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674 doi:10.1016/j.cell.2011.02.013
27. Gatenby, R.A. and Gillies, R.J. (2004) Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4, 891-899 doi:10.1038/nrc1478
28. Gogvadze, V., Orrenius, S
29. Weinhouse, S., Shatton, J.B., Criss, W.E. and Morris, H.P. (1972) Molecular forms of enzymes in cancer. Biochimie 54, 685-693 doi:10.1016/S0300-9084(72)80167-6
30. Bettum, I.J., Gorad, S.S., Barkovskaya, A., Pettersen, S., Moestue, S.A., Vasiliauskaite, K. et al. (2015) Metabolic reprogramming supports the invasive phenotype in malignant melanoma. Cancer Lett. 366, 71-83 doi:10.1016/j.canlet.2015.06.006
31. Iyer, N.V., Kotch, L.E., Agani, F., Leung, S.W., Laughner, E., Wenger, R.H. et al. (1998) Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1a. Genes Dev. 12, 149-162 doi:10.1101/gad.12.2.149
32. Kim, J.-w., Tchernyshyov, I., Semenza, G.L. and Dang, C.V. (2006) HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3, 177-185 doi:10.1016/j.cmet.2006.02.002
33. Papandreou, I., Cairns, R.A., Fontana, L., Lim, A.L. and Denko, N.C. (2006) HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 3, 187-197 doi:10.1016/j.cmet.2006.01.012
34. Seagroves, T.N., Ryan, H.E., Lu, H., Wouters, B.G., Knapp, M., Thibault, P. et al. (2001) Transcription factor HIF-1 is a necessary mediator of the Pasteur effect in mammalian cells. Mol. Cell. Biol. 21, 3436-3444 doi:10.1128/MCB.21.10.3436-3444.2001
35. Quinn, B.J., Kitagawa, H., Memmott, R.M., Gills, J.J. and Dennis, P.A. (2013) Repositioning metformin for cancer prevention and treatment. Trends Endocrinol. Metab. 24, 469-480 doi:10.1016/j.tem.2013.05.004
36. Yu, H., Bian, X., Gu, D. and He, X. (2016) Metformin synergistically enhances cisplatin-induced cytotoxicity in esophageal squamous cancer cells under glucose-deprivation conditions. Biomed. Res. Int. 2016, 8 doi:10.1155/2016/8678634
37. El-Mir, M.-Y., Nogueira, V., Fontaine, E., Averet, N., Rigoulet, M. and Leverve, X. (2000) Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J. Biol. Chem. 275, 223-228 doi:10.1074/jbc.275.1.223
38. Owen, M.R., Doran, E. and Halestrap, A.P. (2000) Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem. J. 348, 607-614 doi:10.1042/bj3480607
39. Gohil, V.M., Sheth, S.A., Nilsson, R., Wojtovich, A.P., Lee, J.H., Perocchi, F. et al. (2010) Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysis. Nat. Biotechnol. 28, 249-255 doi:10.1038/nbt.1606
40. Marroquin, L.D., Hynes, J., Dykens, J.A., Jamieson, J.D. and Will, Y. (2007) Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants. Toxicol. Sci. 97, 539-547 doi:10.1093/toxsci/kfm052
41. Park, S.G., Lee, J.H., Lee, W.A. and Han, K.M. (2012) Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma. Nucl. Med. Biol. 39, 1167-1172 doi:10.1016/j.nucmedbio.2012.07.003
42. Riedl, C.C., Brader, P., Zanzonico, P., Reid, V., Woo, Y., Wen, B. et al. (2008) Tumor hypoxia imaging in orthotopic liver tumors and peritoneal metastasis: a comparative study featuring dynamic 18F-MISO and 124I-IAZG PET in the same study cohort. Eur. J. Nucl. Med. Mol. Imaging 35, 39-46 doi:10.1007/s00259-007-0522-2
43. Yen, T.C., See, L.C., Lai, C.H., Yah-Huei, C.W., Ng, K.K., Ma, S.Y., et al. (2004) 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression. J. Nucl. Med. 45, 22-29 PMID: 14734665
44. Barron, C.C., Bilan, P.J., Tsakiridis, T. and Tsiani, E. (2016) Facilitative glucose transporters: implications for cancer detection, prognosis and treatment. Metabolism 65, 124-139 doi:10.1016/j.metabol.2015.10.007
45. Sotgia, F., Martinez-Outschoorn, U.E., Pavlides, S., Howell, A., Pestell, R.G. and Lisanti, M.P. (2011) Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment. Breast Cancer Res. 13, 213 doi:10.1186/bcr2892
46. Weiler-Sagie, M., Bushelev, O., Epelbaum, R., Dann, E.J., Haim, N., Avivi, I. et al. (2010) 18F-FDG avidity in lymphoma readdressed: a study of 766 patients. J. Nucl. Med. 51, 25-30 doi:10.2967/jnumed.109.067892
47. Aldinucci, D., Gloghini, A., Pinto, A., De Filippi, R. and Carbone, A. (2010) The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape. J. Pathol. 221, 248-263 doi:10.1002/path.2711
48. Pavlides, S., Whitaker-Menezes, D., Castello-Cros, R., Flomenberg, N., Witkiewicz, A.K., Frank, P.G. et al. (2009) The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 8, 3984-4001 doi:10.4161/cc.8.23.10238
49. Wallace, D.C. (2012) Mitochondria and cancer. Nat. Rev. Cancer 12, 685-698 doi:10.1038/nrc3365
50. Martinez-Outschoorn, U.E., Lin, Z., Trimmer, C., Flomenberg, N., Wang, C., Pavlides, S. et al. (2011) Cancer cells metabolically 'fertilize' the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors. Cell Cycle 10, 2504-2520 doi:10. 4161/cc.10.15.16585
51. Whitaker-Menezes, D., Martinez-Outschoorn, U.E., Lin, Z., Ertel, A., Flomenberg, N., Witkiewicz, A.K. et al. (2011) Evidence for a stromal-epithelial 'lactate shuttle' in human tumors. Cell Cycle 10, 1772-1783 doi:10.4161/cc.10.11.15659
52. Gladden, L.B. (2004) Lactate metabolism: a new paradigm for the third millennium. J. Physiol. 558, 5-30 doi:10.1113/jphysiol.2003.058701
53. Goodwin, M.L., Gladden, L.B., Nijsten, M.W.N. and Jones, K.B. (2015) Lactate and cancer: revisiting the Warburg effect in an era of lactate shuttling. Front. Nutr. 1, 27 doi:10.3389/fnut.2014.00027
54. Itoh, Y., Esaki, T., Shimoji, K., Cook, M., Law, M. J., Kaufman, E. et al. (2003) Dichloroacetate effects on glucose and lactate oxidation by neurons and astroglia in vitro and on glucose utilization by brain in vivo. Proc. Natl Acad. Sci. USA 100, 4879-4884 doi:10.1073/pnas.0831078100
55. Yoshida, G.J. (2015) Metabolic reprogramming: the emerging concept and associated therapeutic strategies. J. Exp. Clin. Cancer Res. 34, 111 doi:10. 1186/s13046-015-0221-y
56. Lee, M. and Yoon, J.-H. (2015) Metabolic interplay between glycolysis and mitochondrial oxidation: the reverse Warburg effect and its therapeutic implication. World J. Biol. Chem. 6, 148-161 doi:10.4331/wjbc.v6.i3.148
57. Sonveaux, P., Végran, F., Schroeder, T., Wergin, M.C., Verrax, J., Rabbani, Z.N. et al. (2008) Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J. Clin. Invest. 118, 3930-3942 doi:10.1172/JCI36843